Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases - 1 Apr 2010

Palma Ana Carolina, Abecasis Ana Barroso, Vercauteren Jurgen, Carvalho Ana Patricia, Cabanas Joaquim, Vandamme Anne-Mieke, Camacho Ricardo Jorge

Abstract excerpt

Europe is currently observing a significant rise in non-B subtypes. Consequently, the effect of genetic variability on therapy response or genotypic resistance interpretation algorithms is an emerging concern. The purpose of this study is to investigate the amino acid substitutions selected under drug pressure in the protease of human immunodeficiency virus type 1 (HIV-1) subtypes B and G, and determine if there...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to HIV Infections

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Protease

Share to HIV Protease Inhibitors

Share to Indinavir

Share to Lopinavir

Share to Pyrimidinones

Share to Sequence Analysis, Protein

Source

Identifiers

PMID: 19577015
DOI: 10.1016/j.meegid.2009.06.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G.PMID 19577015Read ↗

Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes.Semantic proximity Read ↗

HIV-1 Genetic Variability and Clinical ImplicationsSemantic proximity Read ↗

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.Semantic proximity Read ↗

Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.Semantic proximity Read ↗

Resistance-associated mutation prevalence according to subtypes B and non-B of HIV type 1 in antiretroviral-experienced patients in Minas Gerais, Brazil.Semantic proximity Read ↗

HIV-1 subtypes: epidemiology and significance for HIV managementSemantic proximity Read ↗

Nucleotide and amino acid polymorphisms at drug resistance sites in non-B-subtype variants of human immunodeficiency virus type 1.Semantic proximity Read ↗

Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates.Semantic proximity Read ↗

Discordant genotypic interpretation and phenotypic role of protease mutations in HIV-1 subtypes B and G.Semantic proximity Read ↗

Drug resistance in non-subtype B HIV-1.Semantic proximity Read ↗

Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.Semantic proximity Read ↗

Drug resistance mutations in HIV pol sequences from Argentinean patients under antiretroviral treatment: subtype, gender, and age issues.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.